PMID: 2484692Jan 1, 1989Paper

On the mechanism of NO release from sydnonimines

Journal of Cardiovascular Pharmacology
M FeelischE A Noack

Abstract

The vasodilator and antiaggregatory properties of sydnonimines like SIN-1 are thought to be due to their marked stimulatory action on soluble guanylate cyclase. Enzyme activation and consecutive cyclic GMP accumulation is mediated by the liberation of nitric oxide (NO) from the open-ring A forms of sydnonimines. The purpose of the present study was to investigate the mechanism of NO release from sydnonimines in direct comparison to their stimulatory effect at the target enzyme, soluble guanylate cyclase. All sydnonimines tested were found to spontaneously liberate NO, the rate of which closely correlated with the extent of enzyme activation. NO release occurred nonlinearly with time and became maximal at high sydnonimine concentration. The in vitro stability of the A forms neither correlated with the measured rate of NO release nor with enzyme activation, indicating that a direct stimulation of guanylate cyclase by the A forms is rather unlikely. Besides NO, all sydnonimines generated NO2- and NO3- at a nearly equimolar rate. The addition of cysteine induced a marked shift from NO3- to NO2- with a small reduction in NO release, which is paralleled by a weak rightward shift of the EC50 at the guanylate cyclase. All tested sydnon...Continue Reading

Citations

Nov 25, 2004·Journal of Neuroscience Research·Erica MartinGary Fiskum
Aug 3, 2010·Cell Biochemistry and Biophysics·Grigory G MartinovichHeinrich Sauer
Jan 1, 1996·Free Radical Biology & Medicine·M W OwensM B Grisham
Jul 24, 2002·Biochemical and Biophysical Research Communications·Teh-Min HuSusan R Mallery
Jul 9, 1997·European Journal of Pharmacology·D K DekaS K Mishra
May 23, 1998·European Journal of Pharmacology·K Stuart-SmithK A Jones
Dec 23, 1999·European Journal of Pharmacology·P AgvaldM G Persson
Dec 28, 1999·European Journal of Pharmacology·V S LemosS F Côrtes
Oct 15, 1998·International Journal for Parasitology·M E SelkirkK Gounaris
Jul 24, 1998·Mutation Research·S ThomasM H Green
Sep 1, 1995·Progress in Cardiovascular Diseases·J Loscalzo, G Welch
Jan 22, 2002·Neuroscience and Biobehavioral Reviews·R M De OliveiraF S Guimarães
Apr 25, 1997·Journal of Neuroscience Methods·D W GodwinQ Zhou
Sep 1, 1996·International Journal of Radiation Oncology, Biology, Physics·R J GriffinC W Song
Jan 1, 1996·Brain Research Bulletin·L Kapás, J M Krueger
Jun 23, 1999·Toxicology Letters·H StopperH H Schmidt
Dec 19, 2000·Free Radical Biology & Medicine·D R Janero, J F Ewing
Jan 1, 1997·Free Radical Biology & Medicine·S PfeifferB Mayer
Apr 29, 1998·Free Radical Biology & Medicine·E E LomonosovaH de Groot
May 22, 2002·Comparative Biochemistry and Physiology. Part A, Molecular & Integrative Physiology·D PellegrinoB Tota
Apr 22, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Henrike HartungStephanie J Cragg
Mar 1, 1997·British Journal of Pharmacology·E AndriambelosonR Andriantsitohaina
Apr 16, 1998·British Journal of Pharmacology·M HernándezU Simonsen
Jul 13, 1999·British Journal of Pharmacology·C AmirmansourR G Bogle

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.